WDR35 and cyst: To test whether integrin-α2β1 inhibition in vivo was sufficient to halt or reverse disease progression, 6-month-old cyst-bearing Wdr35-/- mice were dosed with TC-I 15 or vehicle alone for 3 weeks (Fig. 4H).